Stay updated on Belzutifan + Cabozantinib in ccRCC Clinical Trial
Sign up to get notified when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.

Latest updates to the Belzutifan + Cabozantinib in ccRCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, as shown on the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedPublications section wording updated to clarify data sources: publications are automatically filled in from PubMed (not created by ClinicalTrials.gov) and a revision tag v3.3.1 was added. The description also slightly rephrases how the publications relate to study results.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice about NIH operations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedThere were no substantive updates to the study details, eligibility criteria, or plan sections; the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check79 days agoChange DetectedTerminology update from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to Belzutifan + Cabozantinib in ccRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.